SCHEMBL4844448

SCHEMBL4844448

NC(=O)C1CC(=O)N(Cc2ccc(Cl)cc2)C1

nearest known ligand 0.76

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
KMT2A Q03164 2/20 0.56
NPC1 O15118 1/20 0.56
RAB9A P51151 1/20 0.56
GAA P10253 1/20 0.53
P2RX7 Q99572 1/20 0.50
PKM P14618 2/20 0.49
HPGD P15428 1/20 0.48
ALDH1A1 P00352 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28882986 0.87 SMN1; SMN2 (0.57) HTTSMN1; SMN2KMT2APKMHPGD
SCHEMBL2525981 0.87 ALDH1A1 (0.60) HTTSMN1; SMN2KMT2ANPC1RAB9A
SCHEMBL4740663 0.87 SMN1; SMN2 (0.76) HTTSMN1; SMN2KMT2AP2RX7PKM
Hydrochloric Acid SCHEMBL1373954 0.85 SMN1; SMN2 (0.74) HTTSMN1; SMN2KMT2AP2RX7PKM
SCHEMBL15415933 0.83 ALDH1A1 (0.64) HTTSMN1; SMN2KMT2AALDH1A1
SCHEMBL13387703 0.83 SMN1; SMN2 (0.59) HTTSMN1; SMN2KMT2AP2RX7PKM
SCHEMBL13379358 0.82 SMN1; SMN2 (0.58) HTTSMN1; SMN2KMT2AP2RX7PKM
SCHEMBL6272090 0.82 KMT2A (0.64) HTTSMN1; SMN2KMT2AP2RX7PKM
SCHEMBL20676018 0.80 SMN1; SMN2 (0.85) HTTSMN1; SMN2NPC1RAB9APKM
SCHEMBL25022751 0.79 SIRT1 (0.59) HTTSMN1; SMN2KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110869363-B 5-membered and bicyclic heterocyclic amides as ROCK inhibitors 百时美施贵宝公司 2024-01-05 CN claimed
CN-115697327-A 5-oxo-pyrrolidine-3-carboxamides as NAV1.8 inhibitors 默沙东有限责任公司 2023-02-03 CN claimed
CN-115697327-A 5-oxo-pyrrolidine-3-carboxamides as NAV1.8 inhibitors 默沙东有限责任公司 2023-02-03 CN disclosed
US-7390830-B1 Remedies or prophylactics for diseases in association with chemokines TEIJIN LIMITED (JP) 2008-06-24 US disclosed
EP-1179341-B1 REMEDIES OR PREVENTIVES FOR DISEASES IN ASSOCIATION WITH CHEMOKINES TEIJIN LTD (JP) 2005-11-09 EP disclosed
CN-1384743-A Remedies or preventives for diseases in association with chemokines TEIJIN LTD (JP) 2002-12-11 CN disclosed
EP-1179341-A1 REMEDIES OR PREVENTIVES FOR DISEASES IN ASSOCIATION WITH CHEMOKINES TEIJIN LIMITED (JP) 2002-02-13 EP disclosed